|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.82 CNY | -0.58% |
|
-1.50% | +11.18% |
| 14/01 | Pulike Biological Engineering Gets Drug Registration Certificate for Chicken Vaccine | MT |
| 09/01 | Pulike Biological Engineering Gets Registration Certificate for Fluralaner Chewable Tablets | MT |
| Capitalization | 472.53Cr 68Cr 58Cr 53Cr 50Cr 93Cr 6.19TCr 97Cr 610.73Cr 242.55Cr 2.99TCr 256.55Cr 251.2Cr 10TCr | P/E ratio 2025 * |
24.5x | P/E ratio 2026 * | 20.3x |
|---|---|---|---|---|---|
| Enterprise value | 472.53Cr 68Cr 58Cr 53Cr 50Cr 93Cr 6.19TCr 97Cr 610.73Cr 242.55Cr 2.99TCr 256.55Cr 251.2Cr 10TCr | EV / Sales 2025 * |
3.95x | EV / Sales 2026 * | 3.46x |
| Free-Float |
52.03% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -0.58% | ||
| 1 week | -1.50% | ||
| Current month | -0.43% | ||
| 1 month | +6.64% | ||
| 3 months | -4.16% | ||
| 6 months | -5.86% | ||
| Current year | +11.18% |
| 1 week | 13.82 |  | 14.2 |
| 1 month | 12.88 | | 14.29 |
| Current year | 12.44 | | 14.29 |
| 1 year | 11.81 | | 15.79 |
| 3 years | 10.8 | | 32.8 |
| 5 years | 10.8 | | 34.9 |
| 10 years | 10.58 | | 34.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fei Hu
CEO | Chief Executive Officer | 53 | 26/02/2020 |
Lian Feng Pei
DFI | Director of Finance/CFO | 53 | 23/03/2011 |
Rui Zhao
SEC | Corporate Secretary | 42 | 04/05/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Ke Zhang
CHM | Chairman | 63 | 23/03/2011 |
Fei Hu
BRD | Director/Board Member | 53 | 23/03/2011 |
Yong Jun Song
BRD | Director/Board Member | 58 | 23/03/2011 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.58% | -1.50% | +3.06% | -55.49% | 68Cr | |
| +0.80% | -0.60% | -19.60% | -26.32% | 5.35TCr | |
| +1.37% | -0.28% | +123.38% | +94.96% | 1.25TCr | |
| -3.63% | +5.65% | -9.42% | +10.75% | 450.25Cr | |
| +0.42% | +2.57% | +13.95% | +21.04% | 357.44Cr | |
| -1.71% | -0.70% | +131.49% | +26.10% | 245.33Cr | |
| +1.94% | -1.53% | +102.79% | +225.00% | 211.83Cr | |
| -0.36% | +4.58% | -39.41% | -1.56% | 164.84Cr | |
| +1.68% | +4.60% | +23.14% | +9.24% | 127.39Cr | |
| -0.89% | -1.25% | +6.17% | -7.70% | 124.48Cr | |
| Average | -0.10% | +0.93% | +33.55% | +29.60% | 834.48Cr | |
| Weighted average by Cap. | +0.54% | -0.07% | +12.16% | +4.84% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 119.75Cr 17Cr 15Cr 13Cr 13Cr 24Cr 1.57TCr 25Cr 154.77Cr 61Cr 757.3Cr 65Cr 64Cr 2.65TCr | 136.45Cr 20Cr 17Cr 15Cr 14Cr 27Cr 1.79TCr 28Cr 176.36Cr 70Cr 862.91Cr 74Cr 73Cr 3.02TCr |
| Net income | 19Cr 2.82Cr 2.37Cr 2.16Cr 2.06Cr 3.84Cr 254.89Cr 3.99Cr 25Cr 9.99Cr 123.03Cr 11Cr 10Cr 429.87Cr | 24Cr 3.42Cr 2.88Cr 2.62Cr 2.5Cr 4.65Cr 309.31Cr 4.84Cr 31Cr 12Cr 149.29Cr 13Cr 13Cr 521.64Cr |
| Net Debt | - | - |
Employees
1,551
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 13.82 ¥ | -0.58% | 24,50,900 |
| 12/26/12 | 13.90 ¥ | -0.86% | 27,82,631 |
| 11/26/11 | 14.02 ¥ | -0.14% | 24,68,064 |
| 10/26/10 | 14.04 ¥ | -0.14% | 27,73,056 |
| 09/26/09 | 14.06 ¥ | +0.21% | 38,79,200 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.82CNY
Average target price
16.91CNY
Spread / Average Target
+22.36%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603566 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition